Axcess Global Sciences LLC v. VitaNav Inc.
1:25-cv-00170
Overview
Parties
Defendant
Plaintiff
Axcess Global Sciences LLC Operating Company
Represented By
3 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon LLP
1313 North Market Street, 6th Floor
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 12,128,020 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 12,496,283 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2025036714 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2026013087 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2026023260 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016623247 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,173,138 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 12,109,182 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 12,251,362 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US12128020
Administration of R-beta-hydroxybutyrate and related compounds in humans
|
Filed: 2024-02-29
Issued: 2024-10-29
|
Active (17.3 yrs remaining)
Expires: 2044-02-29
|
|
|
US12109182
Administration of R-beta-hydroxybutyrate and related compounds in humans
|
Filed: 2021-07-02
Issued: 2024-10-08
|
Active (12.4 yrs remaining)
Expires: 2039-04-29
|
|
|
US12090129
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
Filed: 2023-07-03
Issued: 2024-09-17
|
Active (16.6 yrs remaining)
Expires: 2043-07-03
|
|
|
US11020362
Beta-hydroxybutyrate mixed salt compositions and methods of use
|
Filed: 2019-12-19
Issued: 2021-06-01
|
Active (13.1 yrs remaining)
Expires: 2039-12-19
|
|
|
US11241403
Beta-hydroxybutyrate mixed salt compositions and methods of use
|
Filed: 2021-03-11
Issued: 2022-02-08
|
Active (14.3 yrs remaining)
Expires: 2041-03-11
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).